PAGB, the consumer healthcare association, has announced the appointment of Michelle Riddalls as its new Chief Executive. She succeeds John Smith, who has led PAGB since July 2015.
The announcement comes in the wake of PAGB’s centenary year and as it embarks on a new five-year strategy focusing on consumer self-care and industry self-regulation.
Riddalls joined PAGB in June 2019 from Pfizer Consumer Healthcare, where she was Director of Regulatory Affairs for the Northern European Cluster. She is currently PAGB’s Senior Director of Regulatory Affairs and Advertising Services and will become Chief Executive effective from 1 April.
Neil Lister, PAGB President and Vice President International and Managing Director UK and Ireland at Perrigo, said: “The PAGB Board is delighted to appoint Michelle Riddalls as Chief Executive. Michelle has brought a wealth of regulatory experience to PAGB since joining us last year and is perfectly placed to lead the association as it enters its second century as the voice of the consumer healthcare industry.
“The industry has a vital role to play in enabling everyone to care for themselves and their families as effectively as possible – now more than ever, as we face the unprecedented health challenge that is Covid-19.
“Michelle’s expertise and leadership skills equip her perfectly to steer the PAGB team as it provides crucial support to our members in the coming weeks and far beyond.”
Riddalls added: “For more than 100 years, PAGB has worked tirelessly and innovatively to ensure best practice and effective self-regulation in the consumer healthcare industry. I am committed to building on that heritage as we embark on the delivery of our new five-year strategy. This is an important time for our industry and I am looking forward to bringing my expertise and experience to my new role at PAGB.”
PAGB represents the manufacturers of branded OTC medicines, self-care medical devices and food supplements in the UK.
